Cue Biopharma (CUE) EBITDA Margin Growth (1y) (2019 - 2025)
Cue Biopharma (CUE) EBITDA Margin Growth (1y) (2019 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
3,609.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,536.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Cue Biopharma |
581.16 Mn |
553.47 Mn |
- |
84,516.00 |
| Date | Value |
|---|
| Dec 31, 2025 |
84,516.00 |
| Sep 30, 2025 |
-8,694.00 |
| Jun 30, 2025 |
9,552.00 |
| Mar 31, 2025 |
-219,230.00 |
| Dec 31, 2024 |
13,519.00 |
| Sep 30, 2024 |
26,422.00 |
| Jun 30, 2024 |
56,894.00 |
| Mar 31, 2024 |
626,058.00 |
| Dec 31, 2023 |
892,850.00 |
| Sep 30, 2023 |
1.57 Mn |
| Jun 30, 2023 |
4.98 Mn |
| Mar 31, 2023 |
-555,418.00 |
| Dec 31, 2022 |
-956,465.00 |
| Sep 30, 2022 |
-1.57 Mn |
| Jun 30, 2022 |
-5.04 Mn |
| Mar 31, 2022 |
-61,983.00 |
| Dec 31, 2021 |
224,786.00 |
| Sep 30, 2021 |
87,056.00 |
| Jun 30, 2021 |
64,118.00 |
| Mar 31, 2021 |
58,978.00 |
